Director Share Purchase

RNS Number : 8968J
Seed Innovations Limited
15 December 2022
 

15 December 2022

SEED Innovations Limited

("SEED" or the "Company")

Director Share Purchase

SEED Innovations Ltd, the AIM-quoted company investing in fast-growing and industry-leading businesses with a focus on the medical cannabis, health, and wellness space, is pleased to announce it has been informed today that on 15 December 2022, Ed McDermott, CEO of SEED, purchased a further 850,000 ordinary shares in the Company at an average price of 2.69p per share. Following this purchase Mr McDermott has a beneficial interest of 4,275,000 shares representing 2.01% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

- Ends -

For further information on the Company please visit:  www.seedinnovations.com   or contact:

 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E:  info@seedinnovations.co  

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

Max Bennett

St Brides Partners Ltd,

Financial PR

E:  info@stbridespartners.co.uk

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ed McDermott 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO of SEED Innovations Limited

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

SEED INNOVATIONS LIMITED

 

b)

 

LEI

 

 

213800KV6ETTB1BRZ435

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

GG00BRK9BQ81



b)

 

Nature of the transaction

 

 

On market purchase of shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




2.69p

850,000







d)

 

Aggregated information




- Aggregated volume

N/A Single transaction



- Price




e)

 

Date of the transaction

 

 

15 December 2022

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFAFMIEESEFE
UK 100

Latest directors dealings